Phathom Pharmaceuticals (PHAT) Payables (2018 - 2026)
Phathom Pharmaceuticals (PHAT) posted quarterly Payables of $5.4 million for Q2 2026, up 33.76% year-over-year from $4.0 million in Q2 2025, and down 15.77% quarter-over-quarter from $6.4 million in Q1 2026.
Phathom Pharmaceuticals (PHAT) Payables (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Payables for 9 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Payables rose 33.76% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (up 33.76% YoY), while the FY2025 annual figure was $5.0 million, down 52.57% from the prior year.
- Payables eased to $5.4 million in Q2 2026 per PHAT's latest filing, from $6.4 million in the prior quarter.
- Across five years, Payables topped out at $12.6 million in Q4 2023 and bottomed at $1.1 million in Q3 2025.
- Historically, Payables has averaged $6.7 million across 5 years, with a median of $6.1 million in 2023.
- Annual changes were most pronounced in 2022 — Payables soared 94.12% — and 2025, when it tumbled 84.93%.
- Phathom Pharmaceuticals' Payables stood at $10.0 million in 2022, then gained by 26.05% to $12.6 million in 2023, then fell by 16.62% to $10.5 million in 2024, then plunged by 52.57% to $5.0 million in 2025, then advanced by 7.59% to $5.4 million in 2026.
- Business Quant data shows PHAT's Payables at $5.4 million in Q2 2026, $6.4 million in Q1 2026, and $5.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | 5.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.36 Mn |
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 4.98 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 4.01 Mn |
| Mar 31, 2025 | 11.62 Mn |
| Dec 31, 2024 | 10.51 Mn |
| Sep 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.66 Mn |
| Mar 31, 2024 | 8.40 Mn |
| Dec 31, 2023 | 12.60 Mn |
| Sep 30, 2023 | 5.79 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | 7.14 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 5.15 Mn |
| Sep 30, 2021 | 5.58 Mn |